PT Siloam International Hospitals Tbk (SILO.JK)
IDR 2570.0
(-0.77%)
IDR 2570.0
(-0.77%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -552.3 Billion IDR | 0.22% |
| 2022 | -553.51 Billion IDR | 59.0% |
| 2021 | -1349.88 Billion IDR | -345.89% |
| 2020 | -302.74 Billion IDR | -621.96% |
| 2019 | -41.93 Billion IDR | -215.95% |
| 2018 | 36.16 Billion IDR | 104.85% |
| 2017 | -746.12 Billion IDR | -25.42% |
| 2016 | -594.9 Billion IDR | -361.39% |
| 2015 | 227.59 Billion IDR | 24.81% |
| 2014 | 182.35 Billion IDR | 365.5% |
| 2013 | -68.68 Billion IDR | -109.8% |
| 2012 | 700.9 Billion IDR | 86.72% |
| 2011 | 375.37 Billion IDR | 67.2% |
| 2010 | 224.49 Billion IDR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 38.85 Billion IDR | 107.03% |
| 2024 Q3 | -461.52 Billion IDR | -164.75% |
| 2024 Q2 | 257.72 Billion IDR | 563.34% |
| 2023 Q3 | -149.28 Billion IDR | -141.89% |
| 2023 Q4 | -552.3 Billion IDR | -269.96% |
| 2023 FY | -552.3 Billion IDR | 0.22% |
| 2023 Q1 | -343.4 Billion IDR | 37.96% |
| 2023 Q2 | 356.35 Billion IDR | 203.77% |
| 2022 Q3 | -700.05 Billion IDR | 1.48% |
| 2022 FY | -553.51 Billion IDR | 59.0% |
| 2022 Q1 | -1079.85 Billion IDR | 20.0% |
| 2022 Q2 | -710.55 Billion IDR | 34.2% |
| 2022 Q4 | -553.51 Billion IDR | 20.93% |
| 2021 Q1 | -355.15 Billion IDR | -17.31% |
| 2021 Q3 | -498.86 Billion IDR | -219.47% |
| 2021 Q2 | -156.15 Billion IDR | 56.03% |
| 2021 Q4 | -1349.88 Billion IDR | -170.59% |
| 2021 FY | -1349.88 Billion IDR | -345.89% |
| 2020 FY | -302.74 Billion IDR | -621.96% |
| 2020 Q1 | 986.82 Billion IDR | 2453.34% |
| 2020 Q4 | -302.74 Billion IDR | -144.97% |
| 2020 Q3 | 673.13 Billion IDR | -36.27% |
| 2020 Q2 | 1056.25 Billion IDR | 7.04% |
| 2019 Q1 | 64.2 Billion IDR | 77.53% |
| 2019 Q4 | -41.93 Billion IDR | -153.68% |
| 2019 Q3 | 78.11 Billion IDR | -41.89% |
| 2019 FY | -41.93 Billion IDR | -215.95% |
| 2019 Q2 | 134.42 Billion IDR | 109.38% |
| 2018 Q4 | 36.16 Billion IDR | 120.05% |
| 2018 FY | 36.16 Billion IDR | 104.85% |
| 2018 Q3 | -180.39 Billion IDR | 26.4% |
| 2018 Q2 | -245.08 Billion IDR | 58.52% |
| 2018 Q1 | -590.8 Billion IDR | 20.82% |
| 2017 Q2 | -188.76 Billion IDR | 60.2% |
| 2017 Q4 | -746.12 Billion IDR | -4619.86% |
| 2017 Q3 | -15.8 Billion IDR | 91.63% |
| 2017 FY | -746.12 Billion IDR | -25.42% |
| 2017 Q1 | -474.3 Billion IDR | 20.27% |
| 2016 Q1 | 203.54 Billion IDR | -10.57% |
| 2016 FY | -594.9 Billion IDR | -361.39% |
| 2016 Q4 | -594.9 Billion IDR | -273.3% |
| 2016 Q3 | 343.27 Billion IDR | 41.83% |
| 2016 Q2 | 242.03 Billion IDR | 18.91% |
| 2015 Q4 | 227.59 Billion IDR | -16.55% |
| 2015 Q3 | 272.72 Billion IDR | 14.05% |
| 2015 Q2 | 239.13 Billion IDR | 7.05% |
| 2015 Q1 | 223.37 Billion IDR | 22.49% |
| 2015 FY | 227.59 Billion IDR | 24.81% |
| 2014 Q2 | -13.04 Billion IDR | 0.45% |
| 2014 Q3 | 59.11 Billion IDR | 553.28% |
| 2014 Q4 | 182.35 Billion IDR | 208.46% |
| 2014 FY | 182.35 Billion IDR | 365.5% |
| 2014 Q1 | -13.1 Billion IDR | 80.92% |
| 2013 Q3 | -488.82 Billion IDR | 0.0% |
| 2013 FY | -68.68 Billion IDR | -109.8% |
| 2013 Q1 | 738 Billion IDR | 5.29% |
| 2013 Q4 | -68.68 Billion IDR | 85.95% |
| 2012 Q4 | 700.9 Billion IDR | 0.0% |
| 2012 FY | 700.9 Billion IDR | 86.72% |
| 2011 FY | 375.37 Billion IDR | 67.2% |
| 2010 FY | 224.49 Billion IDR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| PT Bundamedik Tbk | 497.89 Billion IDR | 210.927% |
| PT Metro Healthcare Indonesia Tbk | 427.86 Billion IDR | 229.082% |
| PT Medikaloka Hermina Tbk | 1405.68 Billion IDR | 139.291% |
| PT Mitra Keluarga Karyasehat Tbk | -839.7 Billion IDR | 34.227% |
| PT Murni Sadar Tbk | 490.08 Billion IDR | 212.696% |
| PT Famon Awal Bros Sedaya Tbk | 252.54 Billion IDR | 318.698% |
| PT Royal Prima Tbk | -26.49 Billion IDR | -1984.682% |
| PT Kedoya Adyaraya Tbk | -57.42 Billion IDR | -861.8% |
| PT Sarana Meditama Metropolitan Tbk | 834.93 Billion IDR | 166.149% |
| PT Sejahteraraya Anugrahjaya Tbk | 1135.04 Billion IDR | 148.659% |